←
Volteface15,058 posts
Volteface avatar

Volteface

@VoltefaceHub

We are an advocacy and communications organisation. Our content platform cultivates fresh thinking and new ideas to reduce drug related harm.

◷ Joined October 2015▧ 1,913 Photos and videos
Paul North avatar
⟳ Volteface retweeted
Paul North@Paul__North·Nov 17

This is great news. But I am not convinced that it’s quite as significant as many are making out. 1. The news cycle at the moment is WILD. Yes it’s big news if you work in the industry and feels exciting, but outside of that it’s a story that lasts a few hours then vanishes. 2. Its success will depend on the end product, not just the fact it’s a big name. If they target an older aging population they will need wide variety of products and imo novel methods not flower. 3. Big corporations that enter the medical cannabis space are often guided by hyper merchants. They mean well to some extent but the prevailing message is one of how amazing the opportunity is rather than the quantity of the offer to patients. 4. The advertising restrictions make unlocking the 65+ demographic unbelievably challenging. It will take a whole lot more than Boots simply bring in the game. Still great news, big win! But seen a few people on social media frame this as “biggest thing to happen in medical cannabis globally” 😬 volteface.uk/boots-launches-…

🇬🇧 MedBud® avatar
⟳ Volteface retweeted
🇬🇧 MedBud®@MedBudUK·Nov 16

Some further details patients may be interested in, we're still sourcing full product information: - The @BootsUK Online Doctor service is run by @LemonaidHealth. - MC prescriptions are handled via the @ScriptAssistUK platform. - Allegedly, they're still preparing to launch fully, with several doctors in the pipeline that haven't been on-boarded yet. - We are expecting just flower and oils at launch. There's also reason to believe 5g flower packs may be available, £38 per 5g, £73 per 10g - though @MHRAgovuk has previously scalded companies for offering bulk discounts (due to incentivising purchasing more meds than may be required). We'll have their formulary up as soon as possible ⌛️

Boots is launching a medical cannabis service- familiar, trusted name bringing medical cannabis to the attention of millions of UK patients. We’re pleased to have trained Boots clinicians and welcomed new members to the Society. lbc.co.uk/article/boots-cann… #MedicalCannabis

Paul North avatar
⟳ Volteface retweeted
Paul North@Paul__North·18 Nov 2024

Nice milestone for the new business - our first commercial filming job for the @UKCanCouncil at @Fieldfisher Law Firm. Cracking event - speakers were spot on and enjoyed recording tons of vox pops with Holly.

Post attachmentPost attachmentPost attachmentPost attachment
Volteface avatar
Volteface@VoltefaceHub·2 Oct 2024

Kamala Harris has taken a bold step, endorsing full cannabis legalisation. She emphasised the need to stop criminalising cannabis use, particularly for marginalised communities disproportionately affected by drug laws. Read more: volteface.me/kamala-harris-s…

Volteface avatar
Volteface@VoltefaceHub·1 Oct 2024

4/ Social stigma forces patients to hide their use or justify it as "medical," perpetuating the divide between recreational and medical users.

Volteface avatar
Volteface@VoltefaceHub·1 Oct 2024

3/ Encounters with police cause anxiety, particularly for marginalised groups. Even with prescriptions, cannabis users feel at risk.

Volteface avatar
Volteface@VoltefaceHub·1 Oct 2024

2/ Patients report stigma in healthcare, where professionals lack training or dismiss cannabis as an illicit drug—even when legally prescribed.

Volteface avatar
Volteface@VoltefaceHub·17 Sep 2024

7/ Schools, universities, and harm reduction services must offer up-to-date, evidence-based education on ketamine’s risks, focusing on safer use and treatment options. Prevention starts with awareness! 🧠

Volteface avatar
Volteface@VoltefaceHub·17 Sep 2024

6/ While we’re not looking at a major crisis, we do need better drug education and harm reduction strategies. Many young people view ketamine as relatively "safe," but long-term health risks like bladder damage are often overlooked.

Volteface avatar
Volteface@VoltefaceHub·17 Sep 2024

5/ Despite its rising popularity, ketamine doesn’t feature prominently in drug-related death stats. Roughly 30 deaths annually are linked to ketamine, often combined with other substances.